Inhibitors of Akt activity

Details for Australian Patent Application No. 2002252614 (hide)

Owner Merck & Co., Inc.

Inventors Graham, Samuel L.; Barnett, Stanley F.; Remy, David C.

Agent Spruson & Ferguson

Pub. Number AU-B-2002252614

PCT Pub. Number WO2002/083138

Priority 60/282,781 10.04.01 US

Filing date 8 April 2002

Wipo publication date 28 October 2002

Acceptance publication date 14 September 2006

International Classifications

A61K 31/498 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine

C07D 241/42 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

Event Publications

17 April 2003 Application Open to Public Inspection

  Published as AU-B-2002252614

14 September 2006 Application Accepted

  Published as AU-B-2002252614

18 January 2007 Standard Patent Sealed

21 January 2010 Amendment Made

  The nature of the amendment is: Amend the patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

1 November 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002252615-METHOD FOR PRODUCING HIGH CARRIER CONCENTRATION P-TYPE TRANSPARENT CONDUCTING OXIDES

2002252613-SYSTEM AND METHOD FOR MANAGING WELDING CONSUMABLES